Oxidative removal of selected endocrine-disruptors and pharmaceuticals in drinking water treatment systems, and identification of degradation products of triclosan

Science of the Total Environment

Volumn 439, Issue , 2012, Pages 18-25

  Wu, Qihua ^a   Shi, Honglan ^a   Adams, Craig D ^a,b   Timmons, Terry ^c   Ma, Yinfa ^a  

^a MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

^b University of Kansas   (United States)

^c MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

Author keywords

Drinking water treatment; Endocrine disruptor; Liquid chromatography tandem mass spectrometry; Oxidative removal; Personal care products; Pharmaceuticals

Indexed keywords

2 ,4-DICHLOROPHENOL; AQUATIC ECOSYSTEM; CLOFIBRIC ACID; CONTINUOUS INPUT; DEGRADATION PRODUCTS; DRINKING WATER SYSTEMS; ENDOCRINE DISRUPTING COMPOUND; ENDOCRINE DISRUPTOR; ENVIRONMENTAL PROBLEMS; FIRST ORDER; FREE CHLORINE; LC-MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; MONOCHLORAMINE; NATURAL WATERS; OXIDATION PROCESS; OXIDATION PRODUCTS; OXIDATIVE TREATMENT; OZONE TREATMENT; PERSONAL CARE PRODUCTS; RELATIVE REACTIVITIES; REMOVAL EFFICIENCIES; TRACE CONCENTRATIONS; TRICLOSAN; VARIOUS PH;

CHLORINE; DEGRADATION; DEIONIZED WATER; DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OZONE; PHENOLS; POTABLE WATER; WATERWORKS;

REACTION KINETICS;

2,4 DICHLOROPHENOL; CHLORINE; CLOFIBRATE; DRINKING WATER; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTRIOL; ESTRONE; ETHINYLESTRADIOL; IBUPROFEN; IOPROMIDE; MONOCHLORAMINE; OZONE; TRICLOSAN;

DEGRADATION; DRINKING WATER; DRUG; ENDOCRINE DISRUPTOR; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATION; POLLUTANT REMOVAL; REACTION KINETICS; WATER TREATMENT;

ARTICLE; BIODEGRADATION; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; OXIDATION; PH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; WATER TREATMENT;

AMMONIUM CHLORIDE; CHROMATOGRAPHY, LIQUID; DRINKING WATER; ENDOCRINE DISRUPTORS; MANGANESE COMPOUNDS; MISSOURI; OXIDANTS; OXIDATION-REDUCTION; OXIDES; PHARMACEUTICAL PREPARATIONS; SODIUM HYPOCHLORITE; TANDEM MASS SPECTROMETRY; TRICLOSAN; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION; WATER QUALITY;

EID: 84867080125     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.08.090     Document Type: Article

References (40)

1. Acero J., Benitez J., Real F., Roldan G. Kinetics of aqueous chlorination of some pharmaceuticals and their elimination from water matrices. Water Res 2010, 44:4158-4170.
2. Adams C., Wang Y., Loftin K., Meyer M. Removal of antibiotics from surface and distilled water in conventional water treatment processes. J Environ Eng ASCE 2002, 128:253-260.
3. Benitez J., Acero J., Real F., Roldan G. Ozonation of pharmaceutical compounds: rate constants and elimination in various water matrices. Chemosphere 2009, 77:53-59.
4. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 2009, 43:597-603.
5. Boyd G.R., Reemtsma H., Grimm D.A., Mitra S. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA, and Ontario, Canada. Sci Total Environ 2003, 311:135-149.
6. Broseus R., Vincent S., Aboulfadl K., Daneshvar A., Sauve S., Barbeau B., et al. Ozone oxidation of pharmaceuticals, endocrine disruptors and pesticides during drinking water treatment. Water Res 2009, 43:4707-4717.
7. Canosa P., Morales S., Rodríguez I., Rubí E., Cela R., Gómez M. Aquatic degradation of triclosan and formation of toxic chlorophenols in presence of low concentrations of free chlorine. Anal Bioanal Chem 2005, 383:1119-1126.
8. Chamberlain E., Wang C., Shi H., Adams C., Ma Y. Oxidative removal and kinetics of fipronil in various oxidation systems for drinking water treatment. J Agric Food Chem 2010, 58:6895-6899.
9. Chen X.J., Richard J., Liu Y.L., Dopp E., Tuerk J., Bester K. Ozonation products of triclosan in advanced wastewater treatment. Water Res 2012, 46(7):2247-2256.
10. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect Suppl 1999, 107:907-938.
11. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 2006, 76:122-159.
12. Hua W., Bennett E.R., Letcher R.J. Ozone treatment and the depletion of detectable pharmaceuticals and atrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada. Water Res 2006, 40:2259-2266.
13. Huber M.M., Canonica S., Park G.-Y., von Gunten U. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ Sci Technol 2003, 37:1016-1024.
14. Huerta-Fontela M., Galceran M.T., Ventura F. Occurrence and removal of pharmaceuticals and hormones through drinking water treatment. Water Res 2011, 45:1432-1442.
15. Jasim S.Y., Irabelli A., Yang P., Ahmed S., Schweitzer L. Presence of pharmaceuticals and pesticides in Detroit riverwater and the effect of ozone on removal. Ozone Sci Eng 2006, 28:415-423.
16. Jiang J., Su Y., Jun M. Oxidation of triclosan by permanganate (Mn(VII)): importance of ligands and in situ formed manganese oxides. Environ Sci Technol 2009, 43:8326-8331.
17. Jiang J., Pang S.Y., Ma J. Oxidation of phenolic endocrine disrupting chemicals by potassium permanganate in synthetic and real waters. Environ Sci Technol 2011, 46:1774-1781.
18. Jjemba P.K. Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicol Environ Saf 2006, 63:113-130.
19. Kirdani R.Y., Burgett M.J. The pK of five estrogens in aqueous solutions. Arch Biochem Biophys 1967, 118:33-36.
20. Klavarioti M., Mantzavinous D., Kassinos D. Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes. Environ Int 2009, 35:402-417.
21. Liyanapatirana C., Gwaltney S., Xia K. Transformation of triclosan by Fe (III)-saturated montmorillonite. Environ Sci Technol 2010, 44(2):668-674.
22. Mompelat S., Le B.B., Thomas O. Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. Environ Int 2009, 35:803-814.
23. Quintana J., Rodil R., Mahia P., Lorenzo S., Rodriguez D. Investigating the chlorination of acidic pharmaceuticals and by-product formation aided by an experimental design methodology. Water Res 2010, 44:243-255.
24. Richardson S.D. Water analysis: emerging contaminants and current issues. Anal Chem 2009, 81:4645-4677.
25. Richardson S.D. Environmental mass spectrometry: emerging contaminants and current issues. Anal Chem 2012, 84:747-778.
26. Richardson S.D., Ternes T.A. Water analysis: emerging contaminants and current issues. Anal Chem 2011, 83:4614-4648.
27. Rule K.L., Ebbett V.R., Vikesland P.J. Formation of chloroform and chlorinated organics by free-chlorine-mediated oxidation of triclosan. Environ Sci Technol 2005, 39:3176-3185.
28. Santiago E., Bila D.M., Krause L.G.T., Dezotti MD́. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents. J Hazard Mater 2007, 149:631-642.
29. Silva B.F., Jelic A., Serna R.L., Mozeto A.A., Petrovic M., Barcelo D. Occurrence and distribution of pharmaceuticals in surface water, suspended solids and sediments of the Ebro river basin, Spain. Chemosphere 2011, 85:1331-1339.
30. Stackelberg P.E., Gibs J., Furlong E.T., Meyer M.T., Zaugg S.D., Lippincott R.L. Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds. Sci Total Environ 2007, 377:255-272.
31. Suarez S., Dodd M.C., Omil F., von Gunten U. Kinetics of triclosan oxidation by aqueous ozone and consequent loss of antibacterial activity: relevance to municipal wastewater ozonation. Water Res 2007, 41:2481-2490.
32. Ternes T.A., Meisenheimer M., McDowell D., Sacher F., Brauch H.J., Gulde B.H., et al. Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 2002, 36:3855-3863.
33. Ternes T.A., Stuber J., Herrmann N., McDowell D., Ried A., Kampmann M., et al. Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?. Water Res 2003, 37:1976-1982.
34. Vieno N.M., Haerkki H., Tuhkanen T., Kronberg L. Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. Environ Sci Technol 2007, 41:5077-5084.
35. Wang C., Shi H., Adams C., Timmons T., Ma Y. Investigation of oxidative and PAC removal of selected pharmaceuticals in various oxidation systems using liquid chromatography tandem mass spectrometry. Glob J Anal Chem 2011, 2:142-151.
36. Wang C., Shi H., Adams C.D., Gamagedara S., Stayton I., Timmons T., et al. Investigation of pharmaceuticals in Missouri natural and drinking water using high performance liquid chromatography-tandem mass spectrometry. Water Res 2011, 45:1818-1828.
37. Westerhoff P., Yoon Y., Snyder S., Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ Sci Technol 2005, 39:6649-6663.
38. Yang B., Ying G.-G., Zhao J.-L., Zhang L.-J., Fang Y.-X., Nghiem L.D. Oxidation of triclosan ferrate: reaction kinetics, products identification and toxicity evaluation. J Hazard Mater 2011, 186(1):227-235.
39. Yoon Y., Ryu J., Oh J., Choi B.G., Snyder S.A. Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea). Sci Total Environ 2010, 408:636-643.
40. Zhang H., Huang C. Oxidative transformation of triclosan and chlorophene by manganese oxides. Environ Sci Technol 2003, 37:2421-2430.